18F-fluoroestradiol (FES)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 18F-fluoroestradiol (FES), covering 2025-12-22 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer [EARLY_Phase 1]